Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

FOXP1 molecular cytogenetics and protein expression analyses in primary cutaneous large B cell lymphoma, leg-type.

1 Feb 2011

Abstract excerpt

FOXP1 protein is expressed in normal activated B cells and overexpressed in a subset of diffuse large B-cell lymphomas, including primary cutaneous large B-cell lymphomas (PCLBCL), leg type. High expression of FOXP1 has been associated to an unfavourable prognosis with independent survival significance. However, little is known regarding the mechanisms underlying the overexpression of FOXP1 in PCLBCL, leg type....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cutaneous lymphoproliferative disorders research
Share to Lymphoma Diagnosis and Treatment
Share to Nail Diseases and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 21154235
DOI: 10.14670/hh-26.213

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

FOXP1 molecular cytogenetics and protein expression analyses in primary cutaneous large B cell lymphoma, leg-type.PMID 21154235Read ↗

FOXP1 protein overexpression is associated with inferior outcome in nodal diffuse large B-cell lymphomas with non-germinal centre phenotype, independent of gains and structural aberrations at 3p14.1.Semantic proximity Read ↗

The significance of FOXP1 in diffuse large B-cell lymphoma.Semantic proximity Read ↗

Forkhead box protein P1 expression in mucosa-associated lymphoid tissue lymphomas predicts poor prognosis and transformation to diffuse large B-cell lymphoma.Semantic proximity Read ↗

Array-Based Comparative Genomic Hybridization Analysis Reveals Recurrent Chromosomal Alterations and Prognostic Parameters in Primary Cutaneous Large B-Cell LymphomaSemantic proximity Read ↗

Immunohistochemical and Molecular Characteristics with Prognostic Significance in Diffuse Large B-Cell LymphomaSemantic proximity Read ↗

Potentially oncogenic B-cell activation–induced smaller isoforms of FOXP1 are highly expressed in the activated B cell–like subtype of DLBCLSemantic proximity Read ↗

High Incidence and Clinical Significance of MYC Rearrangements in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type.Semantic proximity Read ↗

Recurrent genomic rearrangements in primary testicular lymphomaSemantic proximity Read ↗

FOXP1 expression is a prognostic biomarker in follicular lymphoma treated with rituximab and chemotherapy.Semantic proximity Read ↗

FOXP1 directly represses transcription of proapoptotic genes and cooperates with NF-κB to promote survival of human B cellsSemantic proximity Read ↗

FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomasSemantic proximity Read ↗

Both FOXP1 and p65 expression are adverse risk factors in diffuse large B-cell lymphoma: a retrospective study in China.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.